Big Problems At A Syringe Supplier Led To B. Braun's $7.8m Settlement With Feds
This article was originally published in The Gray Sheet
The company distributed contaminated syringes manufactured by a third party despite repeated indications that not all was well with the supplier's practices, the Department of Justice says.
You may also be interested in...
Services that help doctors' offices navigate payment hurdles could draw government scrutiny for false claims, kickbacks, and medical privacy violations, attorney says.
Reimbursement efforts, individual liability and innovative corporate integrity agreements were among areas of focus at a recent Food and Drug Institute enforcement forum.
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.